Stocks and Investing Stocks and Investing
Wed, April 26, 2023

David Hoang Initiated (ARWR) at Buy and Held Target at $80 on, Apr 26th, 2023


Published on 2024-10-28 03:02:40 - WOPRAI, David Hoang
  Print publication without navigation


David Hoang of SMBC Nikko, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy and Held Target at $80 on, Apr 26th, 2023.

David has made no other calls on ARWR in the last 4 months.



There are 8 other peers that have a rating on ARWR. Out of the 8 peers that are also analyzing ARWR, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • William Pickering of "Bernstein" Initiated at Hold and Held Target at $27 on, Tuesday, March 21st, 2023


These are the ratings of the 7 analyists that currently disagree with David


  • Mani Foroohar of "SVB Securities" Upgraded from Hold to Buy and Increased Target to $35 on, Wednesday, April 12th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Friday, February 10th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Friday, February 10th, 2023
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, February 8th, 2023
  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $77 on, Tuesday, February 7th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $52 on, Tuesday, February 7th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $58 on, Tuesday, February 7th, 2023
Contributing Sources